UC HEALTH LINE: Multidisciplinary Team Focuses on Preventing Diabetic Kidney Failure
Nephrologists Janet Boyle, MD, and
Diabetics are more prone to develop renal disease because their kidneys ability to filter harmful substances from the blood is already severely impaired, says Boyle, assistant professor of medicine at UC. The idea is to catch and begin treating kidney problems as soon as possiblein the early stages of diseaseso we can prolong kidney function and give patients a better quality of life.
Located near the middle of the back, kidneys are bean-shaped organs that keep the bodys blood supply clean and chemically balanced by filtering out waste products and excess water.
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDKD) estimates that more than 8 million adults have chronic kidney disease. This condition, which causes gradual loss of kidney function, can be silent for many years prior to diagnosis. Patients with it are at increased risk of dying from a stroke or heart attack.
Kant and Boyle believe a proactive, multidisciplinary approach to diabetic care that involves nephrologists, diabetes specialists and nurse educators can slow the progression ofand possibly even eliminatechronic kidney disease in people with diabetes.
Research has shown that early diagnosis and careful control of blood glucose (sugar) levels and blood pressure, combined with certain medications used to control diabetes, can lessen the severity of kidney disease for diabetic patients.
If we can prescribe the right balance of medications to manage high blood pressure and reduce the amount of protein in their urine, adds Boyle, we can preserve kidney function and help diabetes patients live longer.
Kant estimates that more than 1 million people will receive regular dialysis (a medical blood-filtering process) to treat chronic kidney disease by 2010. If their condition is left unchecked, he says, most diabetic patients will develop chronic kidney disease within several years of diagnosis.
But with strategic medical management of the disease, adds Kant, we may be able to eliminate the need for dialysis in people with chronic kidney disease. That would help reduce health care costs and improve the lives of thousands of people.
According to the American Diabetes Association (ADA), more than $92 million is spent in the
Physicians stress that there are no definitive signs of chronic kidney disease, but people with diabetes and high blood pressure are at greatest risk.
To schedule an appointment with Boyle or Kant at the UC Diabetes Center, call (513) 475-8200.
Kotagal Kant, MD, is a professor of medicine at UC.
Janet Boyle, MD, is an assistant professor of medicine at UC.
Tags
Related Stories
Scientists: Slushy snowmelt isn’t just a nuisance
February 13, 2026
Slushy snowmelt isn’t just a nuisance, scientists say. It can send a toxic flood of road salt, sand and car exhaust, as well as dog poop, into rivers and streams, The University of Cincinnati College of Medicine's Yevgen Nazarenko, PhD, assistant professor of environmental and industrial hygiene in the Department of Environmental and Public Health Sciences, recently told The New York Times that research has shined a light on how pollution from all sorts of vehicles — planes, cars, trucks — can get trapped in the snow.
Can Cincinnati become a Blue Zone?
February 12, 2026
Under the Blue Zones Project umbrella, 75 U.S. cities currently are working on group diet and exercise programs while also changing the community’s culture, so that residents are encouraged to make healthy choices. Cincinnati is not an official Blue Zones Project city yet, but Florence Rothenberg, MD, adjunct professor of cardiology at the University of Cincinnati College of Medicine and clinical cardiologist at the Cincinnati VA Medical Center, is leading one public effort to encourage a Blue Zone lifestyle. Her work was recently featured in Cincinnati Magazine.
Ride Cincinnati grant funds research on immune activating wafer for glioblastoma treatment
February 12, 2026
MSN UK highlighted University of Cincinnati Cancer Center researchers studying the use of a delayed release preparation or wafer of an immunostimulatory molecule known as IL-15 to stimulate the central nervous system immune system after surgery to remove glioblastoma brain tumors.